focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.00
Ask: 5.50
Change: -0.25 (-5.00%)
Spread: 1.50 (37.50%)
Open: 5.00
High: 5.00
Low: 4.75
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Management Change

12 Nov 2008 07:00

RNS Number : 9571H
Braveheart Investment Group plc
12 November 2008
 



For release 07.00, 12 November 2008

Braveheart Investment Group plc

("Braveheart" or the "Group")

NEW APPOINTMENTS

Braveheart appoints Director of Marketing

Braveheart (AIM: BRH), the technology commercialisation and investment management company, today announces the appointment of Richard Nunneley as the Group's Director of Marketing. This is an entirely new position Braveheart has created to help fulfil the Group's growth strategy outside Scotland and as such Richard will be based in the Group's London office. 

Richard spent his early career with BZW training as a Fund manager. He subsequently joined the Army in 1974 and retired from the Black Watch in 1991. Following this he returned to fund management, starting at Brown Shipley Stockbrokers and going on to become a Director at Mercury Asset Management and Cazenove. He now joins Braveheart from Kaupthing Singer and Friedlander where he served as a Director since 2006. Richard is multi-lingual and also serves as a Non-executive director of Cap Gemini Financial Services.

In addition, Braveheart's Legal Counsel, Stephen Hart, who has been on secondment at Braveheart since April, has now joined the Group permanently. Stephen studied for his law degree and master's degree in European & International trade law at the University of Leicester and trained with Maclay Murray & Spens in London qualifying as an English solicitor in September 2001. He became an associate with Maclays in Edinburgh in 2007, practicing a wide variety of corporate work with particular expertise in private equity, joint ventures, funds and partnerships. 

 

Commenting on the appointments, Geoffrey Thomson, Chief Executive of Braveheart said

 "As previously announced we are keen to broaden Braveheart's presence throughout the UK to ensure we are well placed for when current market turbulence improves. Richard's appointment will be crucial in demonstrating our wider focus and achieving a presence in the South. As well as this new appointment we are delighted that we have been able to retain Stephen Hart's services, thus further strengthening our Corporate Finance function."

For further information please visit www.braveheart-ventures.co.uk or contact:

Braveheart Investment Group

Tavistock Communications

Geoffrey Thomson, Chief Executive

Simon Hudson / James Midmer

Tel: 01738 587555

Tel: 020 7920 3150

gthomson@braveheart-ventures.co.uk

jmidmer@tavistock.co.uk 

Notes to Editors

Braveheart Investment Group is a technology commercialisation and investment management company based in Perth, Scotland. Since its formation in 1997 it has made the transition from start-up angel syndicate to fully listed company. Braveheart's shares listed on AIM in March 2007.

Investments are made in young, emerging, unlisted companies where there is potential for significant growth through successful commercialisation of IP and Braveheart enjoys close relationships with several universities to identify emerging technologies. Investments are predominantly technology-focused; however the Group also maintains limited exposure to more traditional businesses.

Braveheart's diverse portfolio currently comprises over 30 companies and it has completed over 70 deals in its ten year history, including 6 IPOs, 3 trade sales and 8 write-offs and has an exit IRR of 33%.

At the 2008 Ernst & Young Entrepreneur of The Year Awards (Scotland) Braveheart CEO Geoffrey Thomson was given a special award recognising his contribution and support of emerging technology businesses in Scotland over the past decade. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILFLDLELLLIT
Date   Source Headline
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSOperational update on Kirkstall Limited
1st Jun 20207:00 amRNSFurther re Paraytec Limited
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20207:00 amRNSHolding in Phasefocus increased and other matters
20th May 20202:05 pmRNSSecond Price Monitoring Extn
20th May 20202:00 pmRNSPrice Monitoring Extension
20th May 202011:05 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
20th May 20209:34 amRNSHolding(s) in Company
19th May 202012:48 pmRNSHolding(s) in Company
11th May 20208:51 amRNSHolding(s) in Company
11th May 20207:01 amRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
7th May 20206:15 pmRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate in response to social media speculation
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFurther re Kirkstall Limited
1st May 20207:00 amRNSFurther Placing to raise £350,000
29th Apr 20204:40 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSPlacing to raise £275,000
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSOperational update re certain investments
14th Apr 20207:00 amRNSOperational update on the Strategic Investments
3rd Mar 20207:00 amRNSOperational Update and Strategic Investments
30th Jan 20207:00 amRNSOperational update on Strategic Investments
12th Dec 20197:00 amRNSFurther investment in Pharm 2 Farm Limited
21st Nov 20197:00 amRNSOperational update on strategic investments
31st Oct 201910:55 amRNSHalf-year Report
28th Oct 20195:12 pmRNSFurther re buying remaining shares of Paraytec
19th Sep 20197:00 amRNSResults of customer trials by Pharm2Farm Limited
18th Sep 20197:00 amRNSDiscussions to buy remaining shares of Paraytec
29th Aug 201912:20 pmRNSResult of AGM
5th Aug 20197:00 amRNSPosting of annual accounts
1st Aug 20193:27 pmRNSREPLACEMENT: Final Results
1st Aug 20197:00 amRNSFinal Results
8th Jul 20197:00 amRNSInvestment in Pharm2Farm Limited
7th Jun 20197:00 amRNSUpdate to the Market
16th Apr 20197:00 amRNSDisposal of Viking Fund Managers Limited
12th Feb 201910:25 amRNSHolding(s) in Company
31st Jan 20195:17 pmRNSHolding(s) in Company
13th Dec 20187:00 amRNSFund Management Division Update
30th Oct 20187:00 amRNSInterim Results
18th Oct 201811:28 amRNSUpdate re Reduction of Share Capital
24th Sep 20189:00 amRNSConversion of Loan Notes in Paraytec Limited
4th Sep 20187:00 amRNSFurther re. Partial Disposal of Investment
21st Aug 20187:00 amRNSPartial Disposal of Investment in Gyrometric

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.